ZFIN ID: ZDB-EXP-240207-13 |
Experiment Conditions Description: chemical treatment by environment: L-dopa, chemical treatment by environment: olmesartan
chemical treatment by environment: L-dopa |
---|
Name: | chemical treatment by environment |
---|---|
Synonyms: | |
Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
Name: | L-dopa |
---|---|
Synonyms: | (-)-3-(3,4-dihydroxyphenyl)-L-alanine, (-)-dopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, 3,4-Dihydroxy-L-phenylalanine, 3,4-DIHYDROXYPHENYLALANINE, 3-Hydroxy-L-tyrosine, beta-(3,4-dihydroxyphenyl)-L-alanine, beta-(3,4-dihydroxyphenyl)alanine, Dihydroxy-L-phenylalanine, Dopar, L-beta-(3,4-Dihydroxyphenyl)alanine, L-dopa, levodopa, levodopum |
Definition: | An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease |
Ontology: | ChEBI [CHEBI:15765] ( EBI ) |
chemical treatment by environment: olmesartan |
---|
Name: | chemical treatment by environment |
---|---|
Synonyms: | |
Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
Name: | olmesartan |
---|---|
Synonyms: | 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid, 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid, olmesartan |
Definition: | |
Ontology: | ChEBI [CHEBI:48416] ( EBI ) |
Publication: | Kim et al., 2021 |
---|